KOMPAS.com - China and Indonesia are on target to have the Jakarta-Bandung high-speed railway project done by 2022. This commitment was reaffirmed during the inaugural meeting of the China-Indonesia high-level dialogue cooperation mechanism in Guiyang recently.
Meanwhile, Indonesia’s state-owned pharmaceutical company Bio Farma official pointed out what should be done concurrently to achieve a target of vaccinating a million people per day in the second semester of 2021.
Below are excerpts from the news in Indonesia, curated by Kompas.com editors:
Jakarta-Bandung High-Speed Railway Project on Schedule for Completion in 2022
China and Indonesia are on target to have the Jakarta-Bandung high-speed railway project done by 2022.
This commitment was reaffirmed during the inaugural meeting of the China-Indonesia high-level dialogue cooperation mechanism, which was co-chaired by Indonesia’s Coordinating Minister for Maritime Affairs and Investment Luhut Binsar Pandjaitan and China’s State Councilor and Foreign Minister Wang Yi on Saturday, June 5, in Guiyang.
A statement issued by China’s Foreign Affairs Ministry said that the project is part of the Belt and Road Initiative (BRI), an investment program to link China with the rest of Asia, Europe, and beyond through large-scale infrastructure projects along the route of the historic Silk Road.
“The two sides will further align the BRI and the vision of Global Maritime Axis to ensure the completion of the Jakarta-Bandung high-speed railway as scheduled,” said the statement on Saturday.
“It is to set a benchmark for the first phase of the projects jointly built by the two countries under BRI,” it added.
The first high-speed railway project in Indonesia was initiated in 2015. With a standard speed of 350 km per hour, the high-speed train will cut the travel time between the capital city of Jakarta and Bandung in West Java to only 40 minutes, faster than the three hours on the existing train service.